Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome

Condition:   Vascular Ehlers-Danlos Syndrome Interventions:   Drug: ACER-002 (celiprolol) 200 mg BID;   Drug: Placebo BID Sponsor:   Acer Therapeutics Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials